These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8076426)

  • 1. Vascular endothelin responsiveness and receptor characteristics in vitro and effects of endothelin receptor blockade in vivo in cyclosporin hypertension.
    Phillips PA; Rolls KA; Burrell LM; Casley D; Aldred KL; Hardy KJ
    Clin Exp Pharmacol Physiol; 1994 Mar; 21(3):223-6. PubMed ID: 8076426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoconstrictor responses to components of the renin-angiotensin system in cyclosporin-induced hypertension in the rat.
    Rolls KA; Phillips PA; Aldred K; Hardy KJ
    Clin Exp Pharmacol Physiol; 1994 Mar; 21(3):227-30. PubMed ID: 8076427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of selective endothelin antagonists on the hemodynamic response to cyclosporin A.
    Davis LS; Haleen SJ; Doherty AM; Cody WL; Keiser JA
    J Am Soc Nephrol; 1994 Jan; 4(7):1448-54. PubMed ID: 8161726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endothelin in the control of peripheral vascular tone in human hypertension.
    Taddei S; Virdis A; Ghiadoni L; Sudano I; Magagna A; Salvetti A
    Heart Fail Rev; 2001 Dec; 6(4):277-85. PubMed ID: 11447302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.
    Fujita K; Matsumura Y; Kita S; Miyazaki Y; Hisaki K; Takaoka M; Morimoto S
    Br J Pharmacol; 1995 Mar; 114(5):925-30. PubMed ID: 7780646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats.
    Johnson RJ; Fink GD; Watts SW; Galligan JJ
    J Hypertens; 2002 Apr; 20(4):665-76. PubMed ID: 11910302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib, but not indomethacin, ameliorates the hypertensive and perivascular fibrotic actions of cyclosporine in rats: role of endothelin signaling.
    El-Mas MM; Helmy MW; Ali RM; El-Gowelli HM
    Toxicol Appl Pharmacol; 2015 Apr; 284(1):1-7. PubMed ID: 25656942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression.
    Li JS; Deng LY; Grove K; Deschepper CF; Schiffrin EL
    Hypertension; 1996 Aug; 28(2):188-95. PubMed ID: 8707380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin subtype B receptor-mediated calcium and contractile responses in small arteries of hypertensive rats.
    Touyz RM; Deng LY; Schiffrin EL
    Hypertension; 1995 Dec; 26(6 Pt 2):1041-5. PubMed ID: 7498964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin receptors mediating vasoconstriction in rat pressurized small arteries.
    Sharifi AM; Schiffrin EL
    Can J Physiol Pharmacol; 1996 Aug; 74(8):934-9. PubMed ID: 8960383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of endothelin receptors in renal microvessels in acute cyclosporine-mediated vasoconstriction in rats.
    Cavarape A; Endlich K; Feletto F; Parekh N; Bartoli E; Steinhausen M
    Kidney Int; 1998 Apr; 53(4):963-9. PubMed ID: 9551405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: role of blood pressure and endothelial function.
    d'Uscio LV; Shaw S; Barton M; Lüscher TF
    Hypertension; 1998 Jun; 31(6):1305-10. PubMed ID: 9622146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.
    Watts SW; Fink GD; Northcott CA; Galligan JJ
    Br J Pharmacol; 2002 Sep; 137(1):69-79. PubMed ID: 12183332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat.
    McCulloch KM; Docherty C; MacLean MR
    Br J Pharmacol; 1998 Apr; 123(8):1621-30. PubMed ID: 9605569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles.
    Lanese DM; Conger JD
    J Clin Invest; 1993 May; 91(5):2144-9. PubMed ID: 8486781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endothelin in regulation of resistance, fluid-exchange, and capacitance functions of the systemic circulation.
    McNeill JR
    Can J Physiol Pharmacol; 2003 Jun; 81(6):522-32. PubMed ID: 12839264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of PABSA, an orally active and highly potent endothelin-receptor antagonist.
    Iwasaki T; Mihara S; Shimamura T; Kawakami M; Hayasaki-Kajiwara Y; Naya N; Fujimoto M; Nakajima M
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):139-47. PubMed ID: 10413080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
    Warner TD; Allcock GH; Vane JR
    Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists.
    Allcock GH; Warner TD; Vane JR
    Br J Pharmacol; 1995 Nov; 116(5):2482-6. PubMed ID: 8581288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.